• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肝脏影像报告和数据系统(LI-RADS)v2018:CT/MRI 诊断类别综述。

Liver Imaging Reporting and Data System (LI-RADS) v2018: Review of the CT/MRI Diagnostic Categories.

机构信息

Department of Radiology, 2013Montefiore Medical Center, Bronx, NY, USA.

出版信息

Can Assoc Radiol J. 2021 Feb;72(1):142-149. doi: 10.1177/0846537119888393. Epub 2020 Jan 24.

DOI:10.1177/0846537119888393
PMID:32063008
Abstract

Liver Imaging Reporting and Data System (LI-RADS) is a comprehensive system that provides standardization in the interpretation and reporting of observations in patients at risk of developing hepatocellular carcinoma (HCC). Computed tomography/magnetic resonance imaging (CT/MRI) LI-RADS v2018 includes 8 diagnostic categories, which reflect the probability of benignity, malignancy in general, or HCC specifically. This article reviews the diagnostic categories of CT/MRI LI-RADS v2018, highlighting the key imaging features, diagnostic criteria, and management implications.

摘要

肝脏影像报告和数据系统(LI-RADS)是一个全面的系统,为在发生肝细胞癌(HCC)风险的患者中观察结果的解释和报告提供了标准化。计算机断层扫描/磁共振成像(CT/MRI)LI-RADS v2018 包括 8 个诊断类别,反映了良性、恶性或 HCC 的总体可能性。本文回顾了 CT/MRI LI-RADS v2018 的诊断类别,重点介绍了关键的影像学特征、诊断标准和管理意义。

相似文献

1
Liver Imaging Reporting and Data System (LI-RADS) v2018: Review of the CT/MRI Diagnostic Categories.肝脏影像报告和数据系统(LI-RADS)v2018:CT/MRI 诊断类别综述。
Can Assoc Radiol J. 2021 Feb;72(1):142-149. doi: 10.1177/0846537119888393. Epub 2020 Jan 24.
2
Diagnostic performance of MR for hepatocellular carcinoma based on LI-RADS v2018, compared with v2017.基于 LI-RADS v2018 的肝细胞癌的 MRI 诊断性能,与 v2017 相比。
J Magn Reson Imaging. 2019 Sep;50(3):746-755. doi: 10.1002/jmri.26640. Epub 2019 Jan 15.
3
Hepatocellular carcinoma (HCC) versus non-HCC: accuracy and reliability of Liver Imaging Reporting and Data System v2018.肝细胞癌(HCC)与非 HCC:肝脏影像报告和数据系统 v2018 的准确性和可靠性。
Abdom Radiol (NY). 2019 Jun;44(6):2116-2132. doi: 10.1007/s00261-019-01948-x.
4
White paper of the Society of Abdominal Radiology hepatocellular carcinoma diagnosis disease-focused panel on LI-RADS v2018 for CT and MRI.美国腹部放射学会肝癌诊断疾病聚焦专家组关于 CT 和 MRI 的 LI-RADS v2018 白皮书。
Abdom Radiol (NY). 2018 Oct;43(10):2625-2642. doi: 10.1007/s00261-018-1744-4.
5
Liver imaging reporting and data system (LI-RADS) v2018: comparison between computed tomography and gadoxetic acid-enhanced magnetic resonance imaging.肝脏影像报告和数据系统(LI-RADS)v2018:计算机断层扫描与钆塞酸增强磁共振成像的比较。
Jpn J Radiol. 2019 Sep;37(9):651-659. doi: 10.1007/s11604-019-00855-x. Epub 2019 Jul 18.
6
User and system pitfalls in liver imaging with LI-RADS.LI-RADS 肝脏成像中的用户和系统陷阱。
J Magn Reson Imaging. 2019 Dec;50(6):1673-1686. doi: 10.1002/jmri.26839. Epub 2019 Jun 18.
7
LI-RADS Version 2017 versus Version 2018: Diagnosis of Hepatocellular Carcinoma on Gadoxetate Disodium-enhanced MRI.LI-RADS 版本 2017 与版本 2018:钆塞酸二钠增强 MRI 诊断肝细胞癌。
Radiology. 2019 Sep;292(3):655-663. doi: 10.1148/radiol.2019182867. Epub 2019 Jul 16.
8
CT/MR LI-RADS 2018: clinical implications and management recommendations.CT/MR LI-RADS 2018:临床意义和管理建议。
Abdom Radiol (NY). 2019 Apr;44(4):1306-1322. doi: 10.1007/s00261-018-1868-6.
9
LI-RADS algorithm: CT and MRI.LI-RADS 算法:CT 和 MRI。
Abdom Radiol (NY). 2018 Jan;43(1):111-126. doi: 10.1007/s00261-017-1228-y.
10
Multimodality Imaging of Hepatocellular Carcinoma: From Diagnosis to Treatment Response Assessment in Everyday Clinical Practice.肝细胞癌的多模态成像:日常临床实践中从诊断到治疗反应评估
Can Assoc Radiol J. 2021 Nov;72(4):714-727. doi: 10.1177/0846537120923982. Epub 2020 May 21.

引用本文的文献

1
Prostate-specific membrane antigen-targeting radiopharmaceuticals: a new frontier in hepatic malignancies.前列腺特异性膜抗原靶向放射性药物:肝脏恶性肿瘤治疗的新前沿
Front Oncol. 2025 Mar 7;15:1547459. doi: 10.3389/fonc.2025.1547459. eCollection 2025.
2
Characterization and Detection Strategy Exploration in Cryptogenic Hepatocellular Carcinoma: Insights From a Super-Aged Region in Japan.隐匿性肝细胞癌的特征及检测策略探索:来自日本一个超高龄地区的见解
Cancer Med. 2025 Jan;14(2):e70490. doi: 10.1002/cam4.70490.
3
Value of magnetic resonance imaging for diagnosis of LR‑3 and LR-4 lesions coexisting with hepatocellular carcinoma.
磁共振成像对合并肝细胞癌的 LR-3 和 LR-4 病变的诊断价值。
Abdom Radiol (NY). 2024 Aug;49(8):2629-2638. doi: 10.1007/s00261-024-04338-0. Epub 2024 Jun 5.
4
Natural History of Indeterminate Liver Nodules in Patients With Advanced Liver Disease: A Multicenter Retrospective Cohort Study.晚期肝病患者不确定肝脏结节的自然史:一项多中心回顾性队列研究。
Am J Gastroenterol. 2024 Nov 1;119(11):2251-2258. doi: 10.14309/ajg.0000000000002827. Epub 2024 Apr 30.
5
Pre-operative enhanced magnetic resonance imaging combined with clinical features predict early recurrence of hepatocellular carcinoma after radical resection.术前增强磁共振成像联合临床特征可预测肝细胞癌根治性切除术后的早期复发。
World J Gastrointest Oncol. 2024 Apr 15;16(4):1192-1203. doi: 10.4251/wjgo.v16.i4.1192.
6
Establishment and Validation of the LI-RADS Morphologic Type II Hepatocellular Carcinoma Early Recurrence Risk Scoring System.LI-RADS 形态学类型 II 肝细胞癌早期复发风险评分系统的建立与验证。
J Gastrointest Surg. 2023 Dec;27(12):2787-2796. doi: 10.1007/s11605-023-05873-9. Epub 2023 Nov 6.
7
Liver Imaging Reporting and Data System (LI-RADS) v2018: differential diagnostic value of ADC values for benign and malignant nodules with moderate probability (LR-3).肝脏影像报告和数据系统(LI-RADS)v2018:表观扩散系数(ADC)值对中度可能性(LR-3)的良性和恶性结节的鉴别诊断价值
Front Oncol. 2023 Aug 22;13:1186290. doi: 10.3389/fonc.2023.1186290. eCollection 2023.
8
Diagnostic Value of CT Delayed Phase Images Added to Gd-EOB-DTPA MRI for HCC Diagnosis in LR-3/4 Lesions.CT延迟期图像联合钆塞酸二钠MRI对肝脏影像报告和数据系统(LR)3/4期肝细胞癌(HCC)诊断的价值
Int J Gen Med. 2023 Jun 12;16:2383-2391. doi: 10.2147/IJGM.S410123. eCollection 2023.
9
Hepatocellular carcinoma: State of the art diagnostic imaging.肝细胞癌:最新诊断成像技术
World J Radiol. 2023 Mar 28;15(3):56-68. doi: 10.4329/wjr.v15.i3.56.
10
Pre-operative MRI features predict early post-operative recurrence of hepatocellular carcinoma with different degrees of pathological differentiation.术前 MRI 特征可预测不同病理分化程度的肝细胞癌术后早期复发。
Radiol Med. 2023 Mar;128(3):261-273. doi: 10.1007/s11547-023-01601-0. Epub 2023 Feb 10.